You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Colorcon
Harvard Business School
Merck
McKesson

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TIZANIDINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Tizanidine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00047580 Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Sp Completed Elan Pharmaceuticals Phase 3 2002-06-01 This study is being conducted to compare the impact of somnolence (sleepiness) on cognition (awareness) as well as the safety and effectiveness of tizanidine hydrochloride capsules versus Zanaflex® (tizanidine hydrochloride tablets) taken while in the fed state (just after a meal) and in the fasted state (before a meal) in patients with moderate to severe spasticity.
NCT00178646 Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity Completed Allergan Phase 4 2002-01-01 The study seeks to compare the effectiveness of three preparations of BOTOX-A® in treating muscle tightness and spasms in the feet and ankles of people with stroke.
NCT00178646 Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity Completed The University of Texas Health Science Center, Houston Phase 4 2002-01-01 The study seeks to compare the effectiveness of three preparations of BOTOX-A® in treating muscle tightness and spasms in the feet and ankles of people with stroke.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Tizanidine Hydrochloride

Condition Name

Condition Name for Tizanidine Hydrochloride
Intervention Trials
Spasticity 3
Multiple Sclerosis 3
Spinal Cord Injury 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Tizanidine Hydrochloride
Intervention Trials
Muscle Spasticity 6
Multiple Sclerosis 4
Neuralgia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Tizanidine Hydrochloride

Trials by Country

Trials by Country for Tizanidine Hydrochloride
Location Trials
United States 29
Canada 4
Israel 3
Korea, Republic of 3
Turkey 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Tizanidine Hydrochloride
Location Trials
California 4
Texas 3
Pennsylvania 2
Illinois 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Tizanidine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Tizanidine Hydrochloride
Clinical Trial Phase Trials
Phase 4 7
Phase 3 2
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Tizanidine Hydrochloride
Clinical Trial Phase Trials
Completed 15
Terminated 2
Enrolling by invitation 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Tizanidine Hydrochloride

Sponsor Name

Sponsor Name for Tizanidine Hydrochloride
Sponsor Trials
Teva GTC 3
Dr. Reddy's Laboratories Limited 2
Acorda Therapeutics 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Tizanidine Hydrochloride
Sponsor Trials
Industry 13
Other 12
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Colorcon
Merck
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.